Ablation beats drug therapy for women and men with A-fib

Partners’ company helps us stay connected during pandemic
16 February 2021
Mexico rises above 2 million confirmed coronavirus cases
17 February 2021

Ablation beats drug therapy for women and men with A-fib

(HealthDay)—For patients with atrial fibrillation (AF), those undergoing ablation have a significantly reduced risk for recurrent AF compared with those receiving drug therapy, regardless of sex, according to a study published in the Feb. 16 issue of Circulation.

Comments are closed.